Loading
Latest filing published 22 Jul 2026 for Xvivo Perfusion Aktiebolag, €43k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Emil Billbäck discloses dealings in Xvivo Perfusion Aktiebolag to Finansinspektionen. The record holds 2 filings, all for trades on 21 July 2026.
Purchases make up the whole of the open-market record (2 purchases, €77k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 22 July 2026: an open-market purchase of €43k, in Xvivo Perfusion Aktiebolag. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations